Mumps Vaccine Trends and Forecast
The future of the global mumps vaccine market looks promising with opportunities in the pediatric clinic, hospital, and NGO markets. The global mumps vaccine market is expected to reach an estimated $1.1 billion by 2030 with a CAGR of 8.6% from 2024 to 2030. The major drivers for this market are the high prevalence and morbidity of mumps infection, the growing demand for efficient and safe mumps vaccines, and rising government support for mumps vaccination programs.
• Lucintel forecasts that, within the product type category, combinational is expected to witness the highest growth over the forecast period due to its advantages like convenience and cost-effectiveness.
• Within the end use category, pediatric clinic will remain the largest segment due to the significant application of mumps vaccine among children.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.
Gain valuable insights for your business decisions with our 150+ page report.
Emerging Trends in the Mumps Vaccine Market
Developing trends in the mumps vaccine market are a testament to changing vaccine technology, increasing coverage efforts, and growing awareness about the prevention of mumps.
• Technological Advancement: Innovations in vaccine formulation and delivery systems contribute to enhancing the efficacy and safety profiles of mumps vaccines.
• Increased Vaccination Coverage: Increased vaccination coverage through public health campaigns and integration into routine immunization programs has expanded protection against mumps globally.
• Booster Doses: There is an increasing emphasis on booster doses, which are crucial for long-term immunity and help neutralize mumps outbreaks associated with waning vaccine protection.
• Global Health Initiatives: Global health initiatives focusing on collaboration for vaccine access and coverage have increased in recent years, particularly in low- and middle-income countries.
• Addressing Vaccine Hesitancy: Public education and communication efforts have been enhanced to address vaccine hesitancy and improve vaccination rates.
This, in turn, acts as a key driver of change within the mumps vaccine market, increasing vaccine efficacy, coverage, and the overall public health response.
Recent Developments in the Mumps Vaccine Market
The development of the mumps vaccine market focuses on improving vaccines, policy changes, and expanding vaccination efforts.
• Development of Improved Vaccine Formulations: New vaccine formulations are designed to enhance safety and efficacy, improving protection against complications caused by mumps infections.
• Booster Doses as a New Priority: Booster doses added to vaccination schedules help address issues of waning immunity and prevent recent mumps outbreaks.
• Expansion of Immunization Programs: Increased efforts are underway to integrate the mumps vaccine into routine immunization programs, particularly in underserved and low-income regions.
• Improved Vaccine Surveillance: Enhancements in monitoring and surveillance systems enable effective tracking of cases and vaccine performance, informing evidence-based public health responses.
• Global Health: Global health collaborations and initiatives have shifted focus toward ensuring access to and coverage of vaccines, particularly in areas where vaccination rates remain low.
Accordingly, these improvements enhance the efficiency and coverage of mumps vaccination programs, contributing to global control of the infection.
Strategic Growth Opportunities for Mumps Vaccine Market
Strategic growth opportunities in the mumps vaccine market include an increasing demand for vaccines, expanded immunization programs, and technological advancements.
• Routine Immunization Programs: Expanding the mumps vaccine into routine immunization programs creates growth opportunities through increased coverage and early childhood protection.
• Booster Dose Programs: Expanding and implementing booster dose programs can address waning immunity and improve long-term protection against mumps.
• Public Health Campaigns: Expanding public health campaigns to create awareness and overcome vaccine hesitancy will increase vaccination rates, thereby lowering the incidence of infectious diseases.
• Global Health Partnerships: Collaborating with global health partners can extend the reach and equity of vaccine access and distribution in low- and middle-income countries, promoting market growth and improving global health.
• Technological Innovations: Investing in new vaccine technologies and delivery systems will improve vaccine efficacy and safety, leading to wider acceptance in the market.
All these strategic opportunities enhance access, efficacy, and coverage for mumps vaccines, driving market growth.
Mumps Vaccine Market Driver and Challenges
Various technological, economic, and regulatory factors are affecting the mumps vaccine market, including both drivers and challenges.
The factors driving the mumps vaccine market include:
• Technological Advancement: The development of innovative vaccines and delivery systems enhances vaccine safety and efficacy, thereby driving market growth.
• Increased Vaccination Awareness: Growing awareness of the importance of vaccination against mumps is leading to higher vaccination rates.
• Government Policies: Favorable government policies and funding for vaccination programs promote market growth by easing vaccine access.
• Global Health Initiatives: International collaborations and health initiatives have improved vaccine availability and access, particularly in resource-poor settings.
Challenges in the mumps vaccine market include:
• Vaccine Supply Challenges: Disruptions in supply chains significantly affect vaccine availability and access, impacting vaccination programs and market stability.
• Vaccine Distribution Challenges: Logistical challenges related to vaccine distribution, especially in remote areas, hinder effective immunization and market growth.
• Ensuring Regulatory Compliance: The complexity of regulatory requirements is challenging and may affect market entry and product availability.
These drivers and challenges shape the mumps vaccine market by influencing vaccine development, coverage, and overall public health outcomes.
List of Mumps Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mumps vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mumps vaccine companies profiled in this report include-
• MedImmune
• Johnson & Johnson
• Merck
• Sanofi
• Serum Institute of India
• Bavarian Nordic
• Astellas Pharma India
• CSL
• Emergent BioSolutions
• GlaxoSmithKline
Mumps Vaccine by Segment
The study includes a forecast for the global mumps vaccine by product type, age group, end use, and region.
Mumps Vaccine Market by Product Type [Analysis by Value from 2018 to 2030]:
• Monovalent
• Combinational
• Divalent
• Trivalent
• Others
Mumps Vaccine Market by Age Group [Analysis by Value from 2018 to 2030]:
• Pediatric
• Adult
Mumps Vaccine Market by End Use [Analysis by Value from 2018 to 2030]:
• Pediatric Clinic
• Hospitals
• NGOs
• Others
Mumps Vaccine Market by Region [Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Mumps Vaccine Market
The advancement of vaccine technology, regional health policies, and growing global health initiatives are driving development in the mumps vaccine market.
• United States: The country has made advancements in vaccine formulation and the adoption of booster doses in response to recent outbreaks. It is also implementing improved monitoring and vaccination campaigns to address declining vaccine coverage and the resurgence of mumps infections.
• China: China has expanded its mumps vaccination program by incorporating it into the general immunization schedule. The country is also focusing on improving vaccine coverage in rural areas and addressing vaccine hesitancy through public education.
• Germany: Germany has developed new vaccination guidelines and increased vaccine accessibility as part of a broader strategy to control mumps. Ensuring adequate vaccination coverage through public health campaigns remains a significant task.
• India: The mumps vaccine market is growing steadily as India strives to improve vaccination outreach in its most under-resourced areas. Efforts are ongoing to integrate the mumps vaccine into the national immunization schedule, while improving logistics for vaccine delivery.
• Japan: Japan has updated its vaccination guidelines to recommend booster doses of the mumps vaccine. The country is also strengthening vaccine surveillance systems to better monitor disease incidence and vaccine performance.
Features of the Global Mumps Vaccine Market
Market Size Estimates: Mumps vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Mumps vaccine market size by product type, age group, end use, and region in terms of value ($B).
Regional Analysis: Mumps vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, age groups, end uses, and regions for the mumps vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mumps vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q.1 What is the mumps vaccine market size?
Answer: The global mumps vaccine market is expected to reach an estimated $1.1 billion by 2030.
Q.2 What is the growth forecast for mumps vaccine market?
Answer: The global mumps vaccine market is expected to grow with a CAGR of 8.6% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the mumps vaccine market?
Answer: The major drivers for this market are high prevalence and morbidity of mumps infection, growing demand for efficient and safe mumps vaccines, and rising government support for mumps vaccination programs.
Q4. What are the major segments for mumps vaccine market?
Answer: The future of the mumps vaccine market looks promising with opportunities in the pediatric clinic, hospital, and NGO markets.
Q5. Who are the key mumps vaccine market companies?
Answer: Some of the key mumps vaccine companies are as follows:
• MedImmune
• Johnson & Johnson
• Merck
• Sanofi
• Serum Institute of India
• Bavarian Nordic
• Astellas Pharma India
• CSL
• Emergent BioSolutions
• GlaxoSmithKline
Q6. Which mumps vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that combinational is expected to witness highest growth over the forecast period due to its advatages like convenience and cost-effectiveness.
Q7. In mumps vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the mumps vaccine market by product type (monovalent, combinational, divalent, trivalent, and others), age group (pediatric and adult), end use (pediatric clinic, hospitals, NGOs, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Mumps Vaccine Market, Mumps Vaccine Market Size, Mumps Vaccine Market Growth, Mumps Vaccine Market Analysis, Mumps Vaccine Market Report, Mumps Vaccine Market Share, Mumps Vaccine Market Trends, Mumps Vaccine Market Forecast, Mumps Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.